This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as a Hybrid Event June 14-17, 2022
In-Person: June 14-16 • Virtual: June 17Philadelphia, PA

Laura Hamm
Senior Director, Corporate Compliance at Aimmune Therapeutics


Laura Hamm is the Senior Compliance Director at Aimmune Therapeutics, which in 2021 launched the first FDA-approved treatment for peanut allergies, and also joined forces with Nestle Health Science’s pharmaceutical division. Launching a novel therapy in parallel with both COVID and a new company integration brought unique compliance challenges and opportunities. Before joining Aimmune, Laura was Compliance Officer of med device manufacturer Stryker’s Neurovascular division, overseeing all elements of Neurovascular’s global compliance program. Laura is passionate about a collaborative approach to compliance, and empowering business partners to achieve objectives with high integrity. Prior to industry, Laura was an educator in the California public school system, focusing on literacy in low-income communities.

Agenda Sessions

  • Monitor Virtual Programs and Field Team Compliance for Successful Adaptation